Yseop was recently featured in mind Health, where Pierre-Louis Durel, VP Strategy & Operations, shared how AI is transforming regulatory writing—and why it is becoming a critical lever for accelerating access to new therapies.
The post Yseop Featured in mind Health: Accelerating Drug Approvals with Regulatory-Grade AI appeared first on Yseop.
The AI transformation underway in life sciences regulatory affairs is understated, yet tangible and grounded. It is a quiet revolution: instead of pursuing speculative intelligence, organizations are applying AI to automate predictable, rules-driven regulatory work.
The post The Quiet Revolution of AI in Regulatory Affairs appeared first on Yseop.
Why do AI pilots fail to scale in life sciences regulatory teams? Based on our experience supporting AI adoption in regulatory environments worldwide, this article explains what successful teams do differently.
The post What Does Successful AI Adoption Look Like in Regulatory Affairs? appeared first on Yseop.